<<

48

6.2. Campus Virchow-Klinikum (CVK) Projected development for 2030

Inpatient cases +2,754

Development Beds +61 Starting position 2019 since 2014 ↗

↗ Inpatient cases 69,450

The predicted increase in inpatient cases is based on the demographically driven increase expected in

Beds 1,227 ↗ +6%- various districts of by 2030.

Outpatient visits 533,234 ↘ 5% Proportion of cases from Emergency Departments ↗ +9% Surgical procedures per year 34,93827% ↗ +1%- Mean case mix index 1.55 ↘ 7% Mean duration of hospitalization in days 5.96 ↗ +4%- Tertiary care proportion ↘ 5%

24% → 0% Staff (full-time) 5,511.4

1,710.8 CVK of which nursing staff ↗+10% +3% +13% of which professorial staff 92.7 ↗ +4%

of which physicians 922.5 - ↗+10% +9% CCM +5% - - +7% ↗+11% Willmersdorf

Tempelhof- Schöneberg +11% +3% +13% Opened in 1906, the hospital is named after Rudolf Virchow, a Berlin-based physician, - Neukölln Treptow- Charité professor and public health politician who died in 1902, having dedicated his life to CBF +3% Köpenick improving universal access to healthcare. Campus Virchow-Klinikum continues to reflect this legacy: a modern hospital, arranged as a garden city and situated in the middle of a +3% +1% highly industrialized and densely populated area of Berlin. The campus still features the +5% hospital’s characteristic, pavilion-style buildings, which are arranged on either side of a central, tree-lined street (Mittelallee). Designed by Ludwig Hoffmann, the campus features a generous network of green spaces. The campus thereby embraces diverse Percentages listed: Predicted district inpatient case numbers for 2030, based on demographic trends environmental influences and addresses requirements for infection and general health for Berlin. promotion. Future plans to transform the campus into a ‘Healing City’ will ensure that Color coding: Proportion of inpatient provided by Campus Virchow-Klinikum in Berlin’s districts in Campus Virchow-Klinikum remains true to the vision and principles of the historical site. 2017 (light gray < 5 %; blue 5–10 %; dark gray > 10 %)

6 Campuses, Infrastructure and Economic Viability Area development We are developing tomorrow’s leading academic medicine centers in cardiology, oncology, and surgery. We are working with external partners to shape ‘the Future of Medicine’ in cell-based solutions. Working alongside Technische Universität Berlin, we are conducting research into new organ models which 2 mimic human physiology.

3

Existing building stock

Financing secured 1

until 2030

until 2040

until 2050

Construction project for the next 10 years (selection) Estimated level of investment needed

1 German Heart Foundation of the German Heart Center Charité (DHZC) as an international center of Center Charité excellence in cardiovascular medicine and research (in planning) until 2030 (DHZC)

2 National Tumor Establishment of a National Tumor Center (NCT) with a focus on personalized until 2040

Center(NCT) medicine (precision oncology, cellular immunotherapy), prevention and innovative 300 Mio. € diagnostics (strategic vision) until 2050

1,550 Mio. € 3 New building for Construction of a new Pharmacy for the production of preparations for use in Pharmacy, CTC and drug and cellular therapy and in state-of-the-art nuclear pharmacy (strategic Nuclear Pharmacy vision). 3,530 Mio. €